ConductScience.org, home

Cell line · CVCL_1348

Papers64

2 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.

PaperJournalYearHow we knowRetractedSource
Genetically engineered RNA inducers of proximity for protein regulation.Nat Commun2026Its Methods give the RRID and name the linePubMed
Effect of Processing Methods on the Chemical Composition and Cytotoxicity Against Esophageal Cancer Cells of Fresh Taraxacum mongolicum Hand.-Mazz. Leaves.Chem Biodivers2026Its Methods give the RRID and name the linePubMed
Alcohol exposure promotes cell communication network 1 cleavage in esophageal adenocarcinoma cells exclusively.J Cell Commun Signal2026Its Methods give the RRID and name the linePubMed
Elevated CHAF1A Suppresses Type I Interferon Production and Causes Immunotherapy Resistance in Esophageal Squamous Cell Carcinoma.Cancer Immunol Res2026Its Methods give the RRID and name the linePubMed
Development of a prognostic prediction model incorporating KDM1B for esophageal squamous cell carcinoma: an integrated transcriptomic and functional analysis.J Gastrointest Oncol2026Its Methods give the RRID and name the linePubMed
Integrative Transcriptomic and Single-Cell Analyses Identify ATP1A1 as a Prognostic and Immune-Associated Factor in Esophageal Cancer.Int J Genomics2026Its Methods give the RRID and name the linePubMed
The AGPS regulatory variant rs113671272 confers esophageal squamous cell carcinoma susceptibility through allele-specific MEIS3 binding and NF-κB activation in Chinese populations.EBioMedicine2026Its Methods give the RRID and name the linePubMed
Lactylome Reprogramming Mediates Therapeutic Response and Adaptation to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma.Mol Cell Proteomics2026Its Methods give the RRID and name the linePubMed
USP5 regulates purine metabolism and represents a therapeutic target in esophageal cancer.Cell Death Dis2026Its Methods give the RRID and name the linePubMed
A Noncanonical RNA-Binding Function of NQO1 Drives Angiogenesis in Esophageal Squamous Cell Carcinoma via Extracellular Vesicle-Mediated AGRN Transfer.Cancer Res2026Its Methods give the RRID and name the linePubMed
NIPAL1 Drives a Metabolic-Epigenetic Feedback Loop to Promote Lactate-Mediated Immune Evasion in Esophageal Cancer.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
Ectopic CD11c Drives SMAD3-Mediated Aberrant Antigen Presentation and Epithelial-Mesenchymal Transition in Esophageal Squamous Cell Carcinoma.Cancer Commun (Lond)2026Its Methods give the RRID and name the linePubMed
pH-responsive selenium nanoplatform for targeted drug release and immune remodeling in microbiota-associated colorectal cancer.J Nanobiotechnology2026Its Methods give the RRID and name the linePubMed
PDIA6 promotes the cell proliferation of ESCC by enhancing the disulfide bond formation in TRAF4.Cell Mol Biol Lett2026Its Methods give the RRID and name the linePubMed
A Circulating GPNMB-Based Multimodal Model Integrates Tumor-Immune Crosstalk to Predict Immunotherapy Response in Esophageal Cancer.Cancer Discov2026Its Methods give the RRID and name the linePubMed
Patient-derived organoid xenografts model esophageal cancer cachexia and enable assessment of anti-inflammatory drug repositioning.iScience2026Its Methods give the RRID and name the linePubMed
Anlotinib inhibits esophageal cancer malignancy by ameliorating the immune microenvironment.Discov Oncol2026Its Methods give the RRID and name the linePubMed
Spatio-Temporal Proteomic Landscape Reveals Early Warning Signals of Esophageal Squamous Cell Carcinoma Progression.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
Clinofibrate Disrupts the SNORA80B/YTHDC1-Driven M6A Modification to Suppress Cholesterol Metabolism and Cisplatin Resistance in ESCC.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
Role of PLEKHA7 in promoting radioresistance in esophageal cancer cells via the inhibition of cuproptosis.J Thorac Dis2025Its Methods give the RRID and name the linePubMed

cell-lines-2026-11-14-0.1.0

Sources 4

  • CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
  • PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
  • NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
  • PubMedNLM's terms
Each source's terms
  • CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
  • PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
  • NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
  • PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_1348/papers